Novavax appeals to ATAGI to change advice as vaccine uptake falls behind

25 September 2022 - Novavax was hailed as the fix to Australia’s low inoculation rate and “the vaccine for anti-vaxxers”. So ...

Read more →

Some hoped FDA approval of Pfizer's COVID vaccine would convince unvaccinated Americans. It didn't, study finds.

6 April 2022 - After the Food and Drug Administration approved Pfizer-BioNTech’s COVID-19 vaccine in August, public health experts were ...

Read more →

Medscape awarded contract from FDA to develop educational programming focused on biosimilars

14 February 2022 - Medscape Education has been awarded a contract from the U.S. FDA for the development of an ...

Read more →

Full FDA approval is needed to overcome vaccine hesitancy

26 July 2021 - As the Delta variant spreads, what is the agency waiting for? ...

Read more →

Factors associated with generic drug uptake in the United States, 2012 to 2017

19 June 2021 - In the United States, brand-name prescription drugs remain expensive until market exclusivity ends and lower cost generics ...

Read more →

EU regulators develop recommendations to forecast demand of medicines

3 June 2021 - The EU Executive Steering Group on Shortages of Medicines Caused by Major Events has adopted a ...

Read more →

Doctors stop offering AstraZeneca jabs over legal risk

11 April 2021 - Many of the nation’s GPs are refusing to offer AstraZeneca’s vaccine to people under 50 until ...

Read more →

Increasingly, Europeans do not trust AstraZeneca’s vaccine

22 March 2021 - Hesitancy could put the continent’s exit strategy from the pandemic at risk. ...

Read more →

It will be six years before the world is vaccinated against COVID-19: experts

10 February 2021 - It will take six years to vaccinate enough of the world’s population to reduce the threat ...

Read more →

Social media disinformation campaigns tied to vaccine hesitancy

29 October 2020 - Social media disinformation campaigns designed to cast doubt on the safety and effectiveness of vaccines are contributing ...

Read more →

Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19

13 August 2020 - While the focus of attention currently is on developing a vaccine against the Coronavirus SARS-CoV-2 to protect ...

Read more →

Prescriptions surged as Trump praised drugs in coronavirus fight

25 April 2020 - Prescriptions for two antimalarial drugs jumped by 46 times the average when the president promoted them on ...

Read more →

Draft Pelosi plan targets drugs lacking biosimilar or generic option

12 September 2019 - While chances of her leaked plan to force lower drug prices in the United States getting through ...

Read more →

We need to make biosimilars easier to get

11 September 2019 - If potential biosimilar manufacturers can’t get their product to market, they won’t proceed with development. ...

Read more →

Biosimilars Forum’s public letter in response to anti-biosimilars Op-Ed

29 August 2019 - Government Should Not “Throw In the Towel on Biosimilars,” They Should Act Now to Unlock Billions ...

Read more →